权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Regulation of RNA Polymerase II transcription by the phosphatase Rtr1

磷酸酶 Rtr1 对 RNA 聚合酶 II 转录的调节

基本信息

批准号：
9532451
负责人：
AMBER L. MOSLEY
金额：
$ 9.8万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-08-01 至 2018-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9532451
关键词：
Address Binding Binding Proteins C-terminal Cells Chromatin Chromatin Structure Code Complex Coupled Coupling DNA DNA Sequence Alteration Data Defect Disease Disease Progression Down-Regulation ENG gene Elongation Factor Event Excision Frequencies Gene Expression Genes Genetic Recombination Genetic Transcription Genome Stability Genomic Instability Goals Histone H3 Histones Human Hybrids Intercistronic Region Link Lysine Maintenance Malignant Neoplasms Mediating Messenger RNA Methylation Modification Pathogenesis Phosphoric Monoester Hydrolases Phosphorylation Phosphorylation Site Post-Translational Protein Processing Process Protein Binding Domain Protein Dephosphorylation Protein phosphatase Proteins Proteomics RNA RNA Polymerase II RNA Processing RNA polymerase II largest subunit Recruitment Activity Regulation Role Serine Site-Directed Mutagenesis Terminator Regions Testing Transcription Elongation Virus Diseases Work Yeasts cleavage factor combat genetic regulatory protein histone methyltransferase histone modification human disease in vitro Assay in vivo mRNA Precursor mRNA Stability nervous system disorder novel prevent protein complex restoration termination factor therapeutic target transcription termination

项目摘要

DESCRIPTION (provided by applicant): Proper regulation of RNA Polymerase II (RNAPII) transcription is required for proper gene expression levels and the maintenance of overall genome stability. The regulation of RNAPII is altered in the pathogenesis of many human diseases including cancer, neurological disorders, and viral infection. In order to combat changes in RNAPII transcription during the course of disease progression, the basic mechanisms that underlie the regulation of RNAPII must be understood. We have identified a novel regulator of RNAPII, an atypical protein phosphatase known as Rtr1 that is conserved from yeast to humans. We have shown that Rtr1 is required for dephosphorylation of a specific serine in a conserved domain in RNAPII known as the CTD. However, the mechanisms that require CTD dephosphorylation during transcription are not understood. In order to determine the precise role of Rtr1 during RNAPII transcription, we will focus on three specific questions: (1) Is Rtr1-dependent CTD dephosphorylation required for recruitment of the mRNA 3' end processing machinery? (2) Does Rtr1-dependent dephosphorylation stimulate the release of phospho-CTD binding proteins? and (3) Does Rtr1 regulate the phosphorylation status of other protein complexes involved in the regulation of RNAPII transcription elongation and termination? By addressing these key questions, we will increase our understanding of the fundamental process of RNAPII transcription which will allow us to define how defects in this process cause human disease.

描述（由申请人提供）：RNA聚合酶II（RNAPII）转录的适当调节是适当基因表达水平和维持整体基因组稳定性所必需的。RNAPII的调节在许多人类疾病的发病机制中改变，包括癌症、神经障碍和病毒感染。为了对抗疾病进展过程中RNAPII转录的变化，必须了解RNAPII调控的基本机制。我们已经确定了一种新的RNAPII调节剂，一种非典型蛋白磷酸酶，称为Rtr1，从酵母到人类都是保守的。我们已经表明，Rtr1是需要在RNAPII中的保守结构域称为CTD的特定丝氨酸的去磷酸化。然而，转录过程中需要CTD去磷酸化的机制尚不清楚。为了确定Rtr1在RNAPII转录过程中的确切作用，我们将重点关注三个具体问题：（1）Rtr1依赖的CTD去磷酸化是否是mRNA 3'端加工机制募集所必需的？(2)Rtr1依赖性去磷酸化是否刺激磷酸化CTD结合蛋白的释放？以及（3）Rtr1是否调节参与RNAPII转录延长和终止调节的其他蛋白质复合物的磷酸化状态？通过解决这些关键问题，我们将增加我们对RNAPII转录的基本过程的理解，这将使我们能够定义这个过程中的缺陷如何导致人类疾病。